Effect of pyridoxine-2-oxoglutarate administration in patients with advanced cirrhosis: control of ammonia pyruvate and lactate high plasma concentrations.
D000596:Amino Acids / Q000097:blood; D000641:Ammonia / Q000097:blood*; D001786:Blood Glucose / Q000378:metabolism; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D006801:Humans; D007773:Lactates / Q000097:blood*; D019344:Lactic Acid; D008103:Liver Cirrhosis / Q000097:blood / Q000188:drug therapy*; D011736:Pyridoxine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011773:Pyruvates / Q000097:blood*; D019289:Pyruvic Acid; D011897:Random Allocation
D000596:Amino Acids; D001786:Blood Glucose; D007773:Lactates; D011773:Pyruvates; C000503:conductase; D019344:Lactic Acid; D000641:Ammonia; D019289:Pyruvic Acid; D011736:Pyridoxine